IR-MED Reports 87.7% Interim Accuracy in Pressure-Injury Study

A peer-reviewed Phase 2 interim analysis of IR-MED’s investigational device reported 87.7% accuracy, 90.0% sensitivity and 87.3% specificity, with accuracy up 6.5 percentage points versus Phase 1. Phase 2 enrollment is ongoing, with completion expected by March 2027.